Dr. Ted Stanley

Dr. Theodore (Ted) Stanley has been associated with the Department of Anesthesiology at the University of Utah for more than 40 years (since 1967). He became a full time member of the Department (as an Assistant Professor) in 1972 and has been a Professor in the Department of Anesthesiology and Research Professor of Surgery from 1978 until the present time. During that interval he and his associates have received over 10 million dollars in government (State and NIH) and pharmaceutical company funding. Dr. Stanley has been directly responsible for the research education of more than 45 anesthesiology and surgical fellows, he has mentored more than 40 foreign (Dutch, German, French, Russian, Japanese, Korean, English and Belgian) and dozens of American medical students; and has guided the early academic careers of countless junior faculty in anesthesiology departments across the United States and Western Europe.

Dr. Stanley is recognized as an international expert in intravenous anesthesia, opioid analgesics, drug delivery systems, human and wildlife immobilization techniques, and, has been a visiting professor of anesthesiology to almost every academic department (and numerous non-academic departments throughout the United States and most of North and South America, Europe, and the Orient). He has also visited, lectured and consulted at numerous veterinary schools, zoos and wildlife parks in the United States, Canada, and Western Europe. He has been a frequent consultant to the United States FBI Hostage Rescue Team and Central Intelligence Agency.

Dr. Stanley has published over 280 research manuscripts, over 65 chapters and books and over 220 abstracts; and, has made over 780 presentations at medical meetings and anesthesiology departments. Ted has been the director or co-director of the University of Utah's annual post-graduate course for the past 35 years.

In the past 23 years, Ted Stanley has become a "serial entrepreneur" and has founded or co-founded eight life-science companies, one transportation company and three research and educational foundations. Dr. Stanley's "Stanley Research Foundation" has donated more than 5 million dollars to the University of Utah and a number of other universities. Ted Stanley currently sits on the Board's of eight life-science companies and is Chairman of three of these Boards: ZARS, NAPE, and NEUROADJUVANTS. Ted also sits on the Boards of three educational foundations.

One of Dr. Stanley's companies, Anesta, became a public company in 1994 and raised approximately 180 million dollars during its public existence. Anesta was sold to a larger pharmaceutical company, Cephalon, in 2000, for approximately 450 million dollars. Anesta's (Cephalon's) most successful product, Actiq, invented by Dr. Stanley in 1983, produced worldwide sales of approximately $625 million dollars in 2006. Over the last eight years, sales of Actiq (approximately 2.5 billion dollars to date) have resulted in royalties of approximately 60 million dollars being sent to the University of Utah. In 2006 Dr. Ted Stanley was awarded the honor: "Mountainwest Entrepreneur of the Year".